Caution in Treating Parkinson's Depression
Caution in Treating Parkinson's Depression

Depression—whether a disease symptom or a response to PD disability—affects many Parkinson's patients. Long-term levodopa treatment may actually contribute to the problem. Treatment with S-adenosylmethionine (SAMe), a natural substance in cells and sometimes used as an antidepressant, has been suggested in treating PD symptoms of depression. However, SAMe depletes dopamine and can produce PD-like changes in animals, causing cell degeneration in the nigra and striatum areas of the brain. [ 1 ]

Similarly, the herb kava (Piper methysticum) may counter the effects of dopamine and reduce the effectiveness of PD medications. [ 2 ]

References

1. Charlton CG. Depletion of nigrostriatal and forebrain tyrosine hydroxylase by S-adenosylmethionine: a model that may explain the occurance of depression in Parkinson's disease. Life Sciences 1997;61:495-502.

2. Schelosky L, et al. Kava and dopamine antagonism. J Neurol Neurosurg Psychiatry 1995;58:639-40.


[SWIRL 2]


Return to "Parkinson's Defense"